ArticleFrontiers in immunology2025

Residual pattern of primary tumor and lymph node in ESCC treated with nCRT with or without pembrolizumab: an analysis from a prospective cohort.

Xuan Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.